RCE-ESMO-ESO Training Course for Rare Cancer Patient Advocates 2022 Online Training

Programme:

Rare Cancers Europe is delighted to announce that the annual RCE-ESMO-ESO rare cancer patient advocates training course will take place from 8 to 10 February 2022.

Throughout three sessions, participants will be informed about the latest relevant updates on the European policy agenda, as well as being able to network and exchange best practices from their local activities. Attendees will also have the opportunity to participate in Patient Cafés focused on rare cancers in the new COVID-19 era and on how digitalisation can benefit rare cancer patients.

The training course stands to be an excellent opportunity for all interested rare cancer patient advocates, and we very much look forward to your participation. It will see speakers from across the European rare cancer community, including rare cancer patient advocates, researchers, oncologists, and other relevant stakeholders.

What’s on the agenda:

Session 1: A crucial time for the European rare cancer policy landscape: Europe’s Beating Cancer Plan and Cancer Mission

Tuesday 8 February, 16.00 - 17.30 CET

The first session of the training course will focus on two key initiatives that demonstrate the European Commission’s continued focus on cancer: Europe's Beating Cancer Plan and Cancer Mission. These are of crucial importance to the rare cancer community, with the session being aimed at equipping patient advocates with the knowledge to capitalise on the opportunities offered by the initiatives.

Session 2: Rare cancers in the new COVID-19 era

Wednesday 9 February, 15.30 -17.45 CET

Structured in a patient café format, the second session will include three brainstorming sub-sessions. The first sub-session is centred on raising awareness on the importance of COVID-19 vaccination. The second sub-session will look at best practices around creating and maintaining digital patient communities during the pandemic. The final sub-session will see contributions from different stakeholders within the rare cancer community, who will share different perspectives and best practice examples with participants on rare cancers in the new COVID-19 era.

Session 3: Cancer care: ensuring that digitalisation benefits rare cancer patients

Thursday 10 February, 16.00 - 17.30 CET

Also structured in a patient café format, this session will be providing an overview of the key developments in digital health due to COVID-19, as well as a focus on how digitalisation impacts the way in which patients receive treatment, the affect on diagnosis, and patient-physician communication.

For additional information, please contact the RCE Secretariat: rarecancerseurope@esmo.org